The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) is providing a valuable opportunity to access innovations considering AI implementation in pharmaceutical devices during the insightful sessions and witness them in action at the focus exhibition.
“It is very interesting to meet experienced colleagues having the same problems and seeing the different ways to solve them”, – Frank Sommerer, Programme Lead Data Quality by Design, Boehringer Ingelheim International GmbH.
This year, AUTOMA+ is going to take place on 18-19 November in Zurich and is gathering top industry players seeking innovative approaches and collaborative solutions to accelerate the industry’s progress.
AI in pharmaceutical devices: integration of the future
Artificial intelligence (AI), with its capacity for machine learning, data analytics and predictive modelling, is transforming pharmaceutical devices into intelligent systems capable of performing complex tasks. From diagnostic tools to washing and disinfection robots, AI integration is making the equipment more efficient, accurate and responsive to industry needs.
Enhancing diagnostic accuracy, patient monitoring and management. One of the significant impacts of AI in pharmaceutical devices is in the realm of diagnostics. AI algorithms can analyse vast amounts of data from various sources, including medical imaging, electronic health records and genomic data, to identify patterns and make accurate predictions. For instance, AI-powered imaging tools can detect anomalies in X-rays, MRIs and CT scans with remarkable precision.
AI-powered devices are also improving patient monitoring and management. Wearable tools equipped with AI can continuously monitor vital signs, detect abnormalities and alert healthcare providers in real-time. This enables proactive management of chronic conditions, reducing the risk of complications and improving patient outcomes.
To share the experience in AI implementation, Helbling Technik Bern AG is joining the AUTOMA+ 2024 as a gold sponsor and exhibitor. Urs Anliker(Head of development team, Medical Embedded Software) is going to talk about the company’s eHealth ecosystem. The system is designed to integrate various devices and applications, creating a cohesive and efficient digital health network. It includes a range of AI-powered equipment, from diagnostic tools to wearable monitors, all interconnected to provide a holistic view of patient health.
Revolutionising cleaning and disinfection processes. AI-powered devices are significantly enhancing cleaning and disinfection processes across multiple sectors, particularly in healthcare environments. These advanced systems leverage artificial intelligence to optimise hygiene protocols, guaranteeing comprehensive and consistent cleanliness. Their key features include automated navigation, real-time monitoring, and adaptive learning capabilities. By reducing the risk of hospital-acquired infections and improving overall patient and staff safety, AI-driven cleaning and disinfection robots represent a significant advancement in maintaining sterile environments and promoting public health.
KEN HYGIENE SYSTEMS A/S, the coffee break sponsor at the AUTOMA+ 2024, is going to showcase its AI-powered robots during the focus exhibition. The robots use AI algorithms to navigate clinical and laboratory settings, ensuring thorough washing and disinfection. They can identify high-touch surfaces and areas that require more frequent cleaning, helping facilities maintain high hygiene standards and comply with regulatory requirements.
Facilitating laboratory and manufacturing operations. AI-powered devices are transforming the pharmaceutical processes by enhancing efficiency, precision, and scalability. Leveraging advanced algorithms, these tools optimise different stages of production, from drug formulation and testing to quality control and packaging. By integrating AI technologies, the pharmaceutical operations become more agile and adaptive, leading to faster development cycles and cost savings.
Robotec Solutions AG, the VIP meetings room sponsor, is joining the AUTOMA+ 2024 to present R-MoMa – the mobile cobot for laboratory and manufacturing. The device is used for distributing samples, replacing containers and consumables and works with bags, test tubes or pipettes. An articulated arm manipulator (the gripper arm) has a permanently installed vision system with AI-supported image evaluation, which it uses to recognize and inspect objects. The R-MoMa cobot exemplifies the potential of AI-driven robotics to enhance operational efficiency and patient care.
AUTOMA+ 2024: Unlocking the Full Potential of AI
By elevating diagnostic accuracy, patient monitoring, and management, improving cleaning and disinfection operations, and facilitating research and development processes, AI-powered medical devices are revolutionising the pharmaceutical landscape. As the industry collectively navigates challenges and embraces the opportunities offered by AI, the future of pharmaceuticals appears exceedingly promising.
The AUTOMA+ Congress is a place where pharmaceutical leaders exchange exclusive insights, demonstrate innovative technologies, and find mutually beneficial partnerships to advance the industry’s development.
“At this event, I have plenty of opportunities and time because people are coming here for networking. It’s a closed event, so we have deeper discussions”, – Alex Raychuk, Founder & CEO, Medentee Limited.
Don’t miss the opportunity to learn more and witness the mentioned innovations first-hand at the AUTOMA+ 2024: https://automa.plus/
